The SEC filed another settled FCPA action stemming from what the Order called “pervasive” practices in the China subsidiary of a multinational firm. This time GlaxoSmithKline plc was charged with internal control violations arising from the conduct of its China …
Year: 2016
This Week In Securities Litigation (Week ending Sept. 30, 2016)
As the government fiscal year draws to an end, the Commission filed a series of enforcement actions. Those included two insider trading cases, an action alleging violations of the whistleblower provisions, another against a community bank tied to allegations about …
This Week In Securities Litigation (Week ending Sept. 30, 2016) Read More »
